drugset / Trial / NCT00125645

Left Ventricular Function After Acute Myocardial Infarction (AMI). Treatment With Angiotensin 2-Receptor Blockade (GLOBAL-Study)

NCT00125645

NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to compare changes in global left ventricular (LV) function after 3 months of treatment with irbesartan compared with usual care in patients with acute myocardial infarction, a wall motion score \>1.3 (EF\>0.40) and signs of diastolic dysfunction. The hypothesis is that an angiotensin 2-receptor inhibitor will improve global left ventricular function.

Timeline

Start
2005-03-01
Primary completion
2011-09-01
Completion
2011-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Irbesartan Small molecule 300 mg Oral

Indications